Skip to main content

and
  1. Article

    Open Access

    Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned

    Antibody–drug conjugates (ADCs) have emerged as a novel therapeutic strategy that has successfully reached patient treatment in different clinical scenarios. ADCs are formed by an antibody against a specific t...

    Alfonso López de Sá, Cristina Díaz-Tejeiro in Journal of Hematology & Oncology (2023)